Home
  • Careers |
  • Media |
  • Investors |
  • Consumers |
  • Healthcare professionals |
  • Select country

    Africa

    • Algeria Algeria
    • Ghana Ghana
    • Kenya Kenya
    • Morocco Morocco
    • Nigeria Nigeria
    • South Africa South Africa

    Asia & the Middle East

    • Bangladesh Bangladesh
    • Cambodia Cambodia
    • China China
    • Egypt Egypt
    • Hong Kong Hong Kong
    • India India
    • Indonesia Indonesia
    • Israel Israel
    • Japan Japan
    • Korea Korea
    • Malaysia Malaysia
    • Myanmar Myanmar
    • Pakistan Pakistan
    • Philippines Philippines
    • Saudi Arabia Saudi Arabia
    • Singapore Singapore
    • Sri Lanka Sri Lanka
    • Taiwan Taiwan
    • Thailand Thailand
    • Turkey Turkey
    • United Arab Emirates United Arab Emirates
    • Uzbekistan Uzbekistan
    • Vietnam Vietnam

    Australasia

    • Australia Australia
    • New Zealand New Zealand

    Europe

    • Albania Albania
    • Armenia Armenia
    • Austria Austria
    • Azerbaijan Azerbaijan
    • Belarus Belarus
    • Belgium Belgium
    • Bosnia & Herz. Bosnia & Herz.
    • Bulgaria Bulgaria
    • Croatia Croatia
    • Cyprus Cyprus
    • Czech Republic Czech Republic
    • Denmark Denmark
    • Estonia Estonia
    • Finland Finland
    • France France
    • Georgia Georgia
    • Germany Germany
    • Greece Greece
    • Hungary Hungary
    • Iceland Iceland
    • Ireland Ireland
    • Italy Italy
    • Kazakhstan Kazakhstan
    • Latvia Latvia
    • Lithuania Lithuania
    • Macedonia Macedonia
    • Malta Malta
    • Moldova Moldova
    • Netherlands Netherlands
    • Norway Norway
    • Poland Poland
    • Portugal Portugal
    • Romania Romania
    • Russia Russia
    • Serbia Serbia
    • Slovakia Slovakia
    • Slovenia Slovenia
    • Spain Spain
    • Sweden Sweden
    • Switzerland Switzerland
    • Ukraine Ukraine
    • United Kingdom United Kingdom

    North America

    • Canada Canada
    • Mexico Mexico
    • United States United States

    South & Central America

    • Trinidad & Tobago Trinidad & Tobago
    • Argentina Argentina
    • Brazil Brazil
    • Chile Chile
    • Colombia Colombia
    • Costa Rica Costa Rica
    • Dominican Republic Dominican Republic
    • Ecuador Ecuador
    • El Salvador El Salvador
    • Guatemala Guatemala
    • Honduras Honduras
    • Jamaica Jamaica
    • Nicaragua Nicaragua
    • Panama Panama
    • Peru Peru
    • Uruguay Uruguay
    • Venezuela Venezuela

    GSK around the world

    Select a country to find out more about GSK around the world.

    • Home

    • Explore GSK

      Health for all

      All about our work fighting disease across the world

      How we do R&D

      Read the stories behind our R&D operations

      Our communities

      Stories about our many community projects around the world

      Business strategy

      Find out what our strategic priorities mean for our research, our people, our products and our partners

      Everyday health

      Find out things you didn't know about our everyday products

      Our planet

      Find out all about our approach to caring for the planet

      Our people

      Find out about what GSK people have been up to, including our local and overseas community volunteers

      Our products

      Find out about GlaxoSmithKline's products.

      The fight against malaria

      The fight against malaria

      Are malaria's days numbered?

      Find out about our fight against malaria

    • Research

      Science & innovation

      Find out how science and innovation underpin our R&D in vaccines, medicines and consumer healthcare.

      Our product pipeline

      A comprehensive list of all our vaccines, medicines and consumer healthcare products.

      How we discover new medicines

      Find out about the process behind the research and discovery of new medicines.

      How we protect against disease

      Find out how GlaxoSmithKline protects against disease.

      Trials in people

      Learn about how our clinical trials work, and also find out how to become a research volunteer yourself.

      Fighting disease in the developing world

      Find out how we research and develop new medicines that treat and prevent diseases of the developing world.

      Our use of animals

      Information on when and how we use animals for research, how we ensure their welfare and how we limit their use.

      R&D locations

      Find locations where GlaxoSmithKline carries out its R&D operations.

      Careers in R&D

      Find out more about career opportunities in GlaxoSmithKline R&D.

      Our product pipeline

      Our product pipeline

      A comprehensive list of all our vaccines, medicines and consumer healthcare products.

      View our product pipeline

    • Partnerships

      Why work with us

      Information on what we can offer you as an alliance partner, from business development and contract services, to academic collaborations and investment.

      Business development

      We know that our alliance partners face unique challenges and opportunities. We work to understand these issues and design an approach to match.

      Academic collaborations

      Find out how we work with academic institutions and who to contact if you are interested in working with us.

      Open innovation

      Find out how we work with partners in R&D and share our expertise, intellectual property and facilities to discover new medicines.

      Innovation and investment

      Find out how we ensure we have a steady supply of great ideas and innovative science from both inside and outside the company.

      Our manufacturing services

      We provide contract manufacturing services in antibiotics, biopharmaceuticals and pharmaceuticals - find out more.

      GSK McLaren partnership

      Find out all about our partnership with McLaren Group.

      Business development

      Business development

      We know that our alliance partners face unique challenges and opportunities. We work to understand these issues and design an approach to match.

      More on business development

    • Responsibility

      Our behaviour

      We strive to behave in an open and honest manner in all that we do – find out how we apply this to our business.

      Our planet

      Learn about our commitment to the environment including our targets to cut emission and waste, and improve efficiency.

      Health for all

      Find out how we are helping improve people’s health and well-being regardless of where they live or their ability to pay.

      Our people

      See how we work to support the development of our people around the world.

      Our 2012 Corporate Responsibility Report

      Our 2012 Corporate Responsibility Report

      5.2
      Mb      Download as a PDF

    • Products

      Our prescription medicines

      Our prescription medicines include treatments for a wide range of conditions such as infections, depression, skin conditions, asthma, heart and circulatory disease and cancer.

      Our vaccines

      We produce more than 30 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, and more.

      Our consumer healthcare products

      We bring dental health products, over-the-counter medicines and nutritional drinks to millions of people.

      ViiV Healthcare products
      • ViiV Healthcare products
      Stiefel products
      • Stiefel products

    • About us

      What we do

      An overview of what GSK does worldwide including information on our three main business areas: Pharmaceuticals, Vaccines and Consumer Healthcare

      Key achievements

      Find out about our key achievements since we became GlaxoSmithKline in 2001

      Board of Directors

      Find out who sits on GSK’s board of directors

      Corporate Executive Team

      Our Corporate Executive Team assists the CEO in managing the business – find out about its members

      Our history

      GSK was formed in 2000 when Glaxo Wellcome plc and SmithKline Beecham merged, but the combined histories of the two companies go back centuries. Find out more with our interactive timeline.

      Governance

      Information on the governance of GlaxoSmithKline, including details on the board committees, information for shareholders, and how we maintain our corporate ethics.

      Contact us

      Find contact details for GlaxoSmithKline's main corporate offices in the UK and US.

      Contact us

      Contact us

      Find contact details for GlaxoSmithKline's main corporate offices in the UK and US.

      View our contact details
  • Press releases
  • From our CEO
  • Speeches & presentations
  • Social media
  • Resource centre
    • Anti-doping
    • Paroxetine
    • Influenza
    • Malaria media resources
  • Media contact details

Paroxetine and adult patients

  • Overview

  • 2006 analysis

  • Article 31 analysis

  • GPRD report

  • Medical information letter

  • Response to US Senator Grassley

Medical information letter

This letter is sent to healthcare professionals in the United States who request information about suicidality in adults taking paroxetine. A similar letter is shared with healthcare professionals in markets outside the US.

Download the medical information letter (US) (PDF 188 KB)

 

  • You are here
  • Home
  • Media
  • Resource centre
  • Paroxetine
  • Paroxetine and adult patients
    • Sitemap /  
    • Terms of use /  
    • Accessibility /  
    • Cookie policy /  
    • Privacy /  
    • Procurement /  
    • Reports & publications /  
    • GSK employees
    • /  
    • Contact us

Page updated on Wednesday 19 September 2012

© 2001-2013 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.